Ora Biomedical, Inc.
PrivateLast Round
Grant
Sep 2, 2024
Est. Valuation
$15M
Total Funding Raised
$2.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ora Biomedical, Inc. is a biotechnology company that uses a proprietary robotics and AI platform for high-throughput drug screening in live animals to discover and develop therapeutics for longevity and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ora Biomedical, Inc. Comparables
Compare Ora Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnitude Biosciences | 87% | |
| vivoVerse | 85% | |
| NemaLife | 84% |
Ora Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 2, 2024 | ||||
| Grant | May 24, 2024 | ||||
| Seed | Jan 26, 2024 | ||||
| Seed | Oct 1, 2023 | ||||
| Pre Seed | Aug 29, 2022 |
Ora Biomedical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| VitaDAO | Seed |
| United States Department of the Air Force | Grant |
| Sand Hill Angels | Pre Seed |
| AFVentures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 71% MoM, reaching 1.6K.
- Jun 1, 2026
Grew 38% QoQ from 8 to 11 employees.
Ora Biomedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ora Biomedical, Inc.'s valuation, stock price, and market status.
Is Ora Biomedical, Inc. a public or private company?
Ora Biomedical, Inc. is a private company.
What is the current stock price of Ora Biomedical, Inc.?
Ora Biomedical, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Ora Biomedical, Inc. worth (valuation)?
Ora Biomedical, Inc.'s valuation is estimated at $15.0M based on funding round data.
Can I buy Ora Biomedical, Inc. stock?
Ora Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ora Biomedical, Inc.'s last funding round?
Ora Biomedical, Inc.'s most recent funding round was Grant on October 1, 2023.
Who are the main investors in Ora Biomedical, Inc.?
Key investors in Ora Biomedical, Inc. include NIH RADx, VitaDAO, Sand Hill Angels.
Will Ora Biomedical, Inc. IPO soon?
No public IPO plans have been announced for Ora Biomedical, Inc..
How can I track Ora Biomedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ora Biomedical, Inc.'s secondary market activity and sign up for updates.